Pancreatic lipase, a key enzyme for lipid absorption, is one of the most important targets for the treatment of obesity, while natural compounds have recently attracted much interest as potential inhibitors of this enzyme. The gene discussed is PNLIP; the disease is obesity due to melanocortin 4 receptor deficiency.